Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
Add more filters










Publication year range
1.
J Surg Res ; 178(1): 487-93, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22484382

ABSTRACT

BACKGROUND: Mixed chimerism with long-term composite tissue allotransplant (CTA) acceptance can be achieved through allogeneic bone marrow transplantation (BMT). The present study investigated the optimal chimerism level by giving different irradiation dosages to recipients to induce tolerance to CTA. METHODS: Chimera were prepared using Brown-Norway and Lewis rats with strong major histocompatibility complex incompatibility. The Lewis rats received 5 mg antilymphocyte globulin (day -1 and 10) and 16 mg/kg cyclosporine (day 0-10) and were separated into groups 1, 2, 3, 4, and 5 according to the day -1 irradiation dosage: 0, 200, 400, 600, and 950 cGy, respectively. The Lewis rats were then reconstituted with 100 × 10(6) T-cell-depleted Brown-Norway bone marrow cells (day 0) and received vascularized Brown-Norway-CTA on day 28. Chimerism was assessed monthly by flow cytometry starting on day 28 after BMT. Graft-versus-host disease (GVHD) was assessed clinically and histologically. RESULTS: Chimerism, 4 weeks after BMT, averaged 0.2%, 9.2%, 30.7%, 58%, and 99.3% in groups 1 to 5, respectively. GVHD occurred as follows: groups 1 and 2, none; group 3, 1 case of GVHD; group 4, 7 cases of GVHD (of which 3 died); and group 5, 10 cases of GVHD (of which 6 died). The percentage of long-term CTA acceptance was 0%, 0%, 90%, 70%, and 40% in groups 1 to 5, respectively. The percentage of regulatory T cells was significantly lower in high-chimerism (≥ 20%, n = 15) than in low-chimerism (<20%, n = 5) rats that accepted CTA long-term . CONCLUSIONS: The chimerism level correlated positively with GVHD occurrence and long-term CTA acceptance but correlated negatively with regulatory T-cell levels. Optimal chimerism for CTA acceptance through pre-CTA BMT and irradiation occurs at 20-50% at day 28 after BMT in the rat model.


Subject(s)
Bone Marrow Transplantation/immunology , Graft vs Host Disease/immunology , Hindlimb/transplantation , Skin Transplantation/immunology , Transplantation Chimera/immunology , Transplantation Tolerance/immunology , Animals , Cell Lineage/immunology , Graft Survival/immunology , Graft vs Host Disease/prevention & control , Hematopoietic Stem Cells/immunology , Histocompatibility/immunology , Histocompatibility/radiation effects , Lymphocyte Depletion/methods , Radiation Dosage , Rats , Rats, Inbred BN , Rats, Inbred Lew , T-Lymphocytes/cytology , T-Lymphocytes/immunology , Transplantation, Homologous
2.
Blood ; 99(9): 3083-8, 2002 May 01.
Article in English | MEDLINE | ID: mdl-11964269

ABSTRACT

In this study, we investigated the possibility of selective depletion of donor alloantigen-specific T cells from C57BL/6 (H-2(b)) mice to prevent graft-versus-host disease (GVHD). These cells were first activated with irradiated BALB/c (H-2(d)) host spleen cells in a 5-day mixed lymphocyte culture. Following this activation, a photoactive rhodamine derivative called 4,5-dibromorhodamine 123 (TH9402), was added. This compound is selectively retained in the mitochondria of activated host-reactive cells but not tumor- or third-party-specific resting cells. The treated cells were subsequently exposed to visible light (514 nm) to deplete the TH9402-enriched activated host-reactive cells. Treatment with photodynamic cell purging process (PDP) inhibited antihost responses measured by cytotoxic T lymphocytes (CTL) by 93%, and interferon-gamma production by 66%. By contrast, anti-BCL1 (BALB/c-origin leukemia/lymphoma) and anti-third-party C3H/HeJ (H-2(k)) responses were preserved. PDP-treated primed C57BL/6 cells were further tested in vivo. All lethally irradiated BALB/c mice inoculated with BCL1 cells and T-cell-depleted bone marrow cells developed leukemia by day +30, with 50% mortality by 100 days. All mice died of GVHD after addition of 5 x 10(6) untreated primed C57BL/6 cells. However, addition of same numbers of PDP-treated cells allowed 90% of the recipients to survive more than 100 days without detectable BCL1 tumor cells and free of GVHD. Moreover, PDP-treated primed C57BL/6 cells retained the ability to induce GVHD in the third-party C3H/HeJ mice. These data suggest that PDP can selectively deplete host alloantigen-specific T cells for GVHD prevention and immune and antileukemia function preserve.


Subject(s)
Graft vs Host Disease/prevention & control , Lymphocyte Depletion/methods , T-Lymphocytes/radiation effects , Transplantation Immunology/radiation effects , Animals , Bone Marrow Transplantation/methods , Female , Graft vs Leukemia Effect/radiation effects , Histocompatibility/radiation effects , Light , Mice , Mice, Inbred Strains , Photosensitizing Agents/pharmacology , Rhodamines/pharmacology , T-Lymphocytes/immunology , T-Lymphocytes, Cytotoxic/cytology , Tumor Cells, Cultured
3.
Vopr Onkol ; 36(10): 1214-20, 1990.
Article in Russian | MEDLINE | ID: mdl-2251817

ABSTRACT

Rabbit bone marrow supernatants were fractionated and purified by Ultrogel and Superose chromatography. A unique fraction promoted engraftment of allogenic bone marrow and enduring hemopoietic chimerism across the histocompatibility (H-2) barrier in lethally irradiated mice. This fraction analysed by reducing SDS-PAGE electrophoresis and transblotted on PVDF membrane or purified by reverse-phase HPLC and SDS-PAGE electrophoresis yielded a main pre-albumin band that was examined for primary structure by Edman degradation. It appeared to be rabbit transferrin. Iron saturated human transferrin, lactotransferrin and egg transferrin (conalbumin) were then tested in irradiated C57B1/6 mice transplanted with bone marrow from histoincompatible BALB/CJ donors. Most mice treated with iron-loaded transferrins survived and developed enduring allogeneic chimerism with no discernible signs of graft-versus-host disease at 10 months posttransplant. Observation of these animals is still carried on. Iron carrier proteins seem to provide a novel unexpected means for achieving a successful engraftment of allogeneic bone marrow in immunologically hostile murine H-2 combinations and may open a new approach in the clinical area.


Subject(s)
Bone Marrow Transplantation/physiology , Bone Marrow/drug effects , H-2 Antigens/immunology , Histocompatibility/drug effects , Transferrin/pharmacology , Animals , Bone Marrow/immunology , Bone Marrow/radiation effects , Bone Marrow Transplantation/methods , Cattle , Chimera/drug effects , Chimera/immunology , Chimera/radiation effects , Conalbumin/analysis , Conalbumin/isolation & purification , Conalbumin/pharmacology , Female , H-2 Antigens/radiation effects , Histocompatibility/immunology , Histocompatibility/radiation effects , Humans , Lactoferrin/analysis , Lactoferrin/isolation & purification , Lactoferrin/pharmacology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Rabbits , Transferrin/analysis , Transferrin/isolation & purification , Whole-Body Irradiation
4.
J Immunol ; 136(3): 898-902, 1986 Feb 01.
Article in English | MEDLINE | ID: mdl-3079802

ABSTRACT

Administration of a rat monoclonal antibody (M7/20) directed against the murine interleukin 2 (IL 2) receptor in combination with sublethal x-irradiation of the recipient significantly enhanced the survival of skin allografts, both when the grafts were MHC disparate from the hosts and when only minor histocompatibility differences were present compared with untreated controls. No prolongation in graft survival was seen with either treatment alone at the dose employed. M7/20 and x-ray-treated allograft recipients also displayed significantly decreased alloantigen-specific reactivity against donor-strain spleen cells in both delayed-type hypersensitivity and cytotoxicity assays. Thus, such combination treatment reduces expression of host immune reactivity against graft determinants by several criteria. This work provides additional evidence that monoclonal antibodies directed against the IL 2 receptor may be useful in clinical transplantation.


Subject(s)
Antibodies, Monoclonal/administration & dosage , Graft Enhancement, Immunologic , Graft Survival , Receptors, Immunologic/immunology , Skin Transplantation , Animals , Cytotoxicity, Immunologic , Female , Graft Enhancement, Immunologic/methods , Graft Survival/radiation effects , Histocompatibility/radiation effects , Hypersensitivity, Delayed/diagnosis , Mice , Mice, Inbred A , Mice, Inbred BALB C , Mice, Inbred C57BL , Minor Histocompatibility Loci/radiation effects , Receptors, Interleukin-2 , Spleen/immunology , Transplantation, Homologous
6.
Dev Comp Immunol ; 6(4): 665-73, 1982.
Article in English | MEDLINE | ID: mdl-7160511

ABSTRACT

In a compound ascidian, Botryllus primigenus Oka, colony specificity or histoincompatibility has been known. Colony specificity is manifested by fusibility between colonies (fusion or nonfusion). It has been suggested that fusibility of a colony depends upon blood and that cellular and humoral factors may participate in the "nonfusion" reaction (NFR), which is induced in the contact area between two incompatible colonies. In the present study, effects of X-irradiation on colony specificity were studied. When the cut surfaces of two colony pieces previously irradiated were brought into contact, only weak NFR took place in the contact area, although fusion has never occurred. By the use of experimental alteration of fusibility, "fusibility alterable index" (FI) of the irradiated colonies were estimated. FI was inversely proportional to dose of X-irradiation. FI of a colony received 3,000 R corresponds to that of about one-fourth in size and FI of a colony received 5,000 R corresponds to that of about one-eighth in size. Therefore, a factor(s) controlling fusibility may be sensitive to X-irradiation.


Subject(s)
Histocompatibility/radiation effects , Urochordata/immunology , Animals , Graft Rejection/radiation effects
9.
Cancer Res ; 37(2): 394-8, 1977 Feb.
Article in English | MEDLINE | ID: mdl-832264

ABSTRACT

Several murine tumors were used to determine whether the phenomenon of tumor inhibition in athymic "nude" mice reported previously could be extended to other tumor systems in nude as well as conventional mice. The results with the L5MF-22 tumor line were confirmed, and similar data were obtained with the K36 leukemia of AKR mice and the LAF-17 leukemia of B10.A origin. This phenomenon of tumor inhibition has been called, tentatively, radioresistant inhibition of tumor and may be explained by one of several possibilities. The immunological origin of such tumor inhibition is supported by various observations. The data on tumor cell proliferation in spleens and liver of lethally irradiated mice were similar to previous findings on hemopoietic histocompatibility-incompatible lymphomas. Additionally, the nude mice were stronger responders against lymphoma cells than were conventional hosts. Another explanation is that the tumor inhibition is due to natural cytotoxicity.


Subject(s)
Graft Rejection , Leukemia, Experimental/immunology , Lymphoma/immunology , Animals , Cell Division , Female , Graft Rejection/radiation effects , Histocompatibility/radiation effects , Liver/immunology , Male , Mice , Mice, Inbred BALB C , Mice, Nude , Neoplasm Transplantation , Neoplasms, Experimental/immunology , Spleen/immunology , Transplantation, Homologous , Transplantation, Isogeneic
SELECTION OF CITATIONS
SEARCH DETAIL
...